Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers

British Journal of Anaesthesia

Volumn 91, Issue 6, 2003, Pages 805-809

  Cronin, A J ^a   Aucutt Walter, N M ^a   Budinetz, T ^a   Bonafide, C P ^a   DiVittore, N A ^a   Gordin, V ^a   Schuler, H G ^a   Bonneau, R H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Analgesics opioid, remifentanil; Cells, natural killer cell activity

Indexed keywords

CHROMIUM 51; FENTANYL; MORPHINE; MU OPIATE RECEPTOR AGONIST; OPIATE; REMIFENTANIL; SODIUM CHLORIDE;

ARTICLE; BLOOD SAMPLING; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG HALF LIFE; DRUG INFUSION; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

EID: 0345099557     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeg273     Document Type: Article

References (18)

1. Webster NR. Opioids and the immune system. Br J Anaesth 1998; 81: 835-6
2. Beilin B, Martin F, Shavit Y, Gale R, Liebeskind J. Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats. Brain Behav Immun 1989; 3: 129-37
3. Carr D, Gebhart B, Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 1993; 264: 1179-86
4. Yeager M, Colacchio T, Yu C, et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995; 83: 500-8
5. Sacerdote P, Gaspani L, Rossoni G, Panerai A, Bianchi M. Effect of the opioid remifentanil on cellular response in the rat. Int Immunopharmacol 2001; 1: 713-9
6. Jacobs R, Karst M, Scheinichen D, et al. Effects of fentanyl on immune functions in man. Int j Immunopharmacol 1999; 21: 445-54
7. Yeager M, Procopio M, DeLeo J, Arruda J, Hildebrandt L, Howell A. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD(+)16 lymphocytes in humans. Anesth Analg 2002; 94: 94-9
8. Spiegel D, Sephton SE. Psychoneuroimmune and endocrine pathways in cancer: effects of stress and support. Semin Clin Neuropsychiatry 2001; 6: 252-65
9. Born J, Lange T, Hansen K, Molle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997; 158: 4454-64
10. Suzuki S, Toyabe S, Moroda T, et al. Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 1997; 110: 500-8
11. Shinkai S, Konishi M, Shephard RJ. Aging, exercise, training, and the immune system. Exerc Immunol Rev 1997; 3: 68-95
12. Shavit Y, Lewis J, Terman G. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 1984; 223: 188-90
13. Weber R, Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 1989; 245: 188-90
14. Nelson C, Schneider G, Lysle D. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation. Brain Behav Immun 2000; 14: 170-84
15. Madden JJ, Whaley WL, Ketelsen D. Opiate binding sites in the cellular immune system: expression and regulation. J Neuroimmunol 1998; 83: 57-62
16. Shavit Y, Depaulis A, Martin F, et al. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci USA 1986; 83: 7114-7
17. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995; 83: 968-75
18. Hogger P. Adverse effects of opioid analgesic treatment are correlated with a significant elevation in plasma epinephrine in healthy humans. Eur J Clin Pharmacol 2000; 56: 463-68